RPAM
Rhenman & Partners Asset Management’s Krystal Biotech KRYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
12,750
-5,000
| -28% | -$687K | 0.22% | 74 |
|
|
2025
Q1 | $3.2M | Sell |
17,750
-6,000
| -25% | -$1.08M | 0.37% | 58 |
|
|
2024
Q4 | $3.72M | Buy |
23,750
+6,750
| +40% | +$1.06M | 0.38% | 62 |
|
|
2024
Q3 | $3.09M | Sell |
17,000
-2,000
| -11% | -$364K | 0.25% | 81 |
|
|
2024
Q2 | $3.49M | Hold |
19,000
| – | – | 0.34% | 67 |
|
|
2024
Q1 | $3.38M | Buy |
+19,000
| New | +$3.38M | 0.32% | 63 |
|